series-b
Stage
2
Investors
About
Auron Therapeutics is a clinical-stage biopharmaceutical company developing therapies targeting dysregulated cellular differentiation and plasticity to treat oncology and inflammatory diseases, using an AI-driven platform to identify cell state-specific targets and biomarkers.
Explore Auron Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.